Astrazeneca AZN
NYSE AZN
$160.15 +0.51 (+0.32%)
As of: Sep 11, 2026 · 3:59 PM EDT

Astrazeneca (AZN) EBIT Margin Growth (1y) (2010 - 2026)

Analysis

Astrazeneca (AZN) EBIT Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Asml Holding 659.69 Bn 643.71 Bn 5.90 Bn -
2 General Electric 337.12 Bn 327.78 Bn 6.95 Bn -357.00
3 Astrazeneca 247.89 Bn 242.60 Bn 12.86 Bn -371.00
4 Citigroup 236.49 Bn -2,065.81 Bn 24.75 Bn 531.00
5 Bhp 220.99 Bn 202.45 Bn - -
6 Rio Tinto 206.31 Bn 201.93 Bn - -
7 Diageo 192.64 Bn 190.61 Bn - -
8 National Grid 165.59 Bn 161.82 Bn - -
9 Unilever 135.28 Bn 128.25 Bn - -
10 Hdfc Bank 119.43 Bn 82.28 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -371.00
Mar 31, 2026 73.00
Dec 31, 2025 475.00
Sep 30, 2025 801.00
Jun 30, 2025 305.00
Mar 31, 2025 253.00
Dec 31, 2024 -697.00
Sep 30, 2024 -214.00
Jun 30, 2024 -134.00
Mar 31, 2024 53.00
Dec 31, 2023 -233.00
Sep 30, 2023 640.00
Jun 30, 2023 1,750.00
Mar 31, 2023 1,642.00
Dec 31, 2022 2,630.00
Sep 30, 2022 2,852.00
Jun 30, 2022 -894.00
Mar 31, 2022 -1,840.00
Dec 31, 2021 -2,375.00
Sep 30, 2021 -3,515.00